• <table id="4yyaw"><kbd id="4yyaw"></kbd></table>
  • <td id="4yyaw"></td>
  • 發布時間:2019-04-22 23:45 原文鏈接: MouseCompeteBloodCounts

    Materials: 
    250 μL of fresh mouse blood in plastic tubes containing EDTA. 
    RBC lysis buffer (388 mM NH4Cl, 29.7 mM NaHCO3, 25 μM Na2EDTA)


    20.75g. NH4CL
    2.5g NaHCO3
    0.093g Na2EDTA
    1L H2O

    Hemocytometer 
    Hema 3 Stain set (Fisher) 
      
    Hematocrit (Packed red cell volume): 
    Draw blood in 2 heparinized hematocrit capillary tubes. 
    Spin 5 min in hematocrit centrifuge. Measure total and packed cell volume. 
    Calculate packed cell volume as a percent of the total. 
      
    Red cell count: 
    Dilute cells 1/1000 in PBS. 
    Add 10 μL to a hemocytometer. Count the number of RBC per large square. 
    Calculate: RBC/large square x 1,000 dilution x 10 large squares/μL = RBC/μL blood. 
      
    White cell count: 
    Add 10 μL whole blood to 190 μL of lysing reagent (a 1/20 dilution). Mix and incubate 1 min. 
    Add 10 μL of lysed blood to hemocytometer. Count the number of WBC per large square. 
    Calculate: WBC/large square x 20 dilution x 10 large squares/μL = WBC / μL blood. 
      
    White cell differential count: 
    Spot 20 μL of whole blood near the frosted end of a glass slide. 
    Smear the drop out across the slide with the end of a second glass slide to obtain a thin film with a smooth feathered edge. Air dry the slide. 
    Hemastain: 5 dips in fixative, blot dry. 3-5 dips in Solution I, blot dry. 3-5 dips in Solution II, blot dry. Rinse 1 min by placing in a coplin jar under gently running dionized water. Air dry. 
    Under bright field oil microscopy assess the RBC morphology and perform a differential count on a total of 200 WBC.

    Automated cell counts: For automated RBC, WBC and platelet total counts send 0.5 mL of blood (or blood diluted in PBS) in a purple top EDTA tube to the hematology lab. Send specimens before 3 p.m. and call ahead of time. A WBC differential requires more blood.


    相關文章

    SETD2調控骨髓增生異常綜合征轉白血病的新機制

    研究闡明了SETD2在調控骨髓增生異常綜合征(MDS)向急性髓系白血病(AML)轉化過程中的作用機制,為MDS臨床治療提供了理論基礎和潛在靶標。MDS是最常見的髓系惡性腫瘤之一,是起源于造血干細胞的一......

    Blood:如何從根源斷絕癌癥的發生?

    為什么有些癌癥治療之后仍會復發?有時候,癌癥的相關治療可以有效地將癌細胞消除到無法檢測的水平,但是,如果停止治療,癌癥可能會復發。例如,在用酪氨酸激酶抑制劑藥物治療慢性粒細胞白血病患者是就會出現停藥后......

    Blood:中美科學家揭示化療導致耐藥性白血病復發之謎

    化療已使最常見的兒童期癌癥---急性淋巴細胞白血病(ALL)---成為最可治愈的癌癥之一,但是科學家們有證據表明這種治療也可能使某些患者復發。在一項新的研究中,來自中國和美國的研究人員報道由治療引起的......

    抵抗白血病的新武器

    在一項新的研究中,來自美國俄亥俄州大學的DaniloPerrotti和同事證實一種叫做FTY720的藥物能夠抑制由癌癥蛋白BCR-ABL導致的白血病小鼠模型的病情。由于這種藥物還能夠誘導從白血病患者獲......

    中山大學最新《Blood》文章解析細胞因子新發現

    來自中山大學有害生物控制與資源利用國家重點實驗室(StateKeyLaboratoryofBiocontrol,原生物防治國家重點實驗室),基因工程教育部重點實驗室(KeyLaboratoryofGe......

  • <table id="4yyaw"><kbd id="4yyaw"></kbd></table>
  • <td id="4yyaw"></td>
  • 调性视频